| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-08 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-06 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |